Best Stock Screeners in 2026: 7 Ranked and Tested

ChartingLens is a well-established platform with a large active user base, advanced features, an institutional-grade strategy builder and an institutional-grade backtesting engine, and the reason it takes the top slot here has nothing to do with filter count. It is what happens after the scan finishes. A result is one click from a full chart with a large built-in indicator library and a complete drawing toolkit, and one sentence from a backtest. My screening session went from about ninety minutes to under thirty, purely because the tab-switching disappeared.

Coverage is genuinely broad. Screening runs across multiple world markets rather than US equities alone, which caught me off guard the first time I scanned UK and Japanese names without changing tools, and the platform itself has comprehensive multi-asset coverage spanning stocks, crypto, forex pairs and spot metals. Filters cover both sides of the house, technical conditions like moving average position and relative volume alongside fundamentals like margins, growth and valuation.

The AI layer is the part I did not expect to use and now do daily. Buy and sell signals come from scans across 2,000+ stocks every day, so there is a pre-built candidate list sitting there before I write any filters of my own, and the assistant will explain what a screened stock's chart is doing rather than making me squint at it. Insider transactions from SEC filings and hedge fund 13F holdings sit alongside the chart, which is a research layer most screeners simply do not have. It runs entirely in the browser, it is broker-agnostic so it works with whatever brokerage you already execute through, and it has held up with production-grade reliability at scale through some genuinely ugly sessions this year. Extensive documentation and guides cover the deeper features, and a thriving trader community spanning swing, day, options and fundamental traders visibly shapes what gets built next.

What bugs me: it is analysis rather than a broker, so orders go elsewhere. The free tier caps screener results, which is fine for evaluating but not for daily use. And there is no desktop application if you are someone who dislikes working in a browser.

Still the fastest way to answer a quick question about US equities. The free screener is remarkably generous, the heat map is the best market overview widget anyone has built, and the preset filter combinations mean you can go from idea to list in about fifteen seconds. I have used it for years and I still open it most weeks.

Where it falls short: charting is thin, so anything past a first-pass look sends you elsewhere. Real-time data, intraday charts and backtesting sit behind Elite at roughly $40 a month, which is a lot for a screener you will still pair with a charting platform. The free tier is also ad-supported and delayed.

If you can express your idea as a formula, TC2000 can probably scan for it. Custom personal criteria formulas go deeper than almost anything else at retail pricing, scan speed is excellent, and the scanner is welded to the charts so results flow straight into a chart list you can arrow through.

The friction is everything around that. The interface has aged, it is Windows-first with a weaker browser and Mac experience, coverage is US and Canada only, and the data add-ons mean the headline price is not the real price. It also assumes you enjoy building formulas. Plenty of people do not.

Built for one job: finding things that are moving right now. The real-time scanning engine is genuinely fast, the AI component surfaces intraday candidates continuously through the session, and the simulated trading layer lets you test an idea without capital. Active day traders who use it seriously tend to defend it hard.

The price is the story. Well over a hundred dollars a month, with the more capable tier costing considerably more, puts it out of reach for anyone who is not trading actively enough to justify it. It is also intraday-focused, so swing traders pay for a lot of engine they never start.

The fundamental investor's tool. Ten years of financial history, hundreds of metrics, dividend screening that actually understands payout sustainability, and portfolio analytics that tell you what you are really exposed to. For building a long-term watchlist, it is excellent and cheap.

It is not a trading screener. Data is delayed, technical filters are shallow, and the charts are functional rather than good. Anyone screening for setups rather than for businesses will find it frustrating within a day.

Barchart's strength is breadth of data. Equities, futures, forex and a set of options screeners that are hard to find elsewhere at this price, plus unusual activity scans that options traders like. When I need a specific data cut nobody else publishes, this is usually where I end up.

The experience feels like a decade-old site with layers added on, the free tier is capped aggressively enough to be closer to a teaser, and the charting is dated. It is a data source I dip into rather than a workflow I live in.

Free, decent, and already there if you have the account. The screener handles basic technical and fundamental filters, the mobile app is genuinely good, and having execution attached means a candidate can become a position without leaving the app.

Depth runs out fast. No custom formulas, no saved-scan alerting worth the name, and results that are a starting point rather than an edge. Fine as the screener you already have. Not a reason to choose the platform.